-
Company Insights
NewUnited Overseas Bank Limited – Digital Transformation Strategies
United Overseas Bank Digital Transformation Strategies Overview United Overseas Bank is exploring the use of advanced technologies such as blockchain, artificial intelligence, big data, and cloud to increase its operational flexibility and efficiency. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of United Overseas Bank was estimated at $835 million in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and...
-
Innovation Ranking
Innovation Ranking – Orient Overseas (International) Ltd
Orient Overseas (International) Ltd (OOIL), a subsidiary of Faulkner Global Holdings Limited is a transport and logistics service providing company. The company engages in the provision of container transport and logistics services, property investment services, and operating of ports and terminals. It involves in transportation businesses and the leasing of equipment. The company provides innovative freight management services, cargo handling, trucking, warehousing and leading-edge IT solutions. OOIL offers information on shipping schedules and vessel tracking for shippers and logistics services....
-
Company Insights
NewAlipay – Competitor Profile
Launched in 2004, Alipay is among the leading alternative payment services providers (PSP) globally. It is a subsidiary of Ant Group, which is controlled by Alibaba Group. Alipay allows users to make fund transfers as well as online, in-app, and in-store payments at home and abroad. It is the primary method of payment for Alibaba’s online marketplaces, including AliExpress, Tmall, and Taobao. Alipay is accepted in more than 110 countries, allowing Chinese tourists to make payments in Chinese renminbi and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Emphysema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Emphysema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Emphysema Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Cryoglobulinemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Cryoglobulinemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Cryoglobulinemia Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Graft Versus Host Disease (GVHD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Graft Versus Host Disease (GVHD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Systemic Sclerosis (Scleroderma) Drug Details: Belimumab (Benlysta) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-026 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-026 in Epilepsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-026 in Epilepsy Drug Details: OPL-026 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-022 in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-022 in Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-022 in Hypertension Drug Details: OPL-022 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-025B in Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-025B in Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-025B in Diabetes Drug Details: OPL-025B is under development for the treatment...